Brian T Hill

9PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 04, 2026
Bendamustine/Rituximab Induction Followed by Venetoclax/Rituximab Consolidation in Frontline Treatment of Chronic Lymphocytic Leukemia: A Phase 2 Multi-Center Study.

|Mar 08, 2024
Lenalidomide, rituximab (R2), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphoma.

Brian T Hill, Yanwen Chen, Deepa Jagadeesh

|Oct 26, 2023
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.

Colleen A Ramsower, Allison Rosenthal, Ryan S Robetorye

|Jun 23, 2022
Sequential loss of B-cell target antigens in multiply relapsed high-grade B-cell lymphoma treated with targeted therapies.

Agrima Mian, Narendra Bhattarai, Michael Sheu

|Sep 28, 2021
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.

Peter A Riedell, Mehdi Hamadani, Kwang W Ahn

|Jan 21, 2020
Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantation.

Hassan Awada, Reda Z Mahfouz, Jibran Durrani

Pageof 2

Frequent Collaborators

2 joint publications

Matthew Maurer

2 joint publications

Jonathon B Cohen

2 joint publications

Alex F Herrera

1 joint publications

Colleen A Ramsower